18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity
Authors:
- 9 May 2009
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (11) , 1794-1802
Abstract
The aim of the study was to assess the accuracy of 18F-fluorodeoxyglucose (FDG) PET/CT in mediastinal lymph node staging of patients with non-small-cell lung cancer (NSCLC) in a region with a high prevalence of granulomatous disease.Keywords
This publication has 32 references indexed in Scilit:
- Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F‐FDG PET/CT in a tuberculosis‐endemic countryCancer, 2007
- The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung CancerThe Oncologist, 2004
- The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancerThe Annals of Thoracic Surgery, 2004
- FDG-PET in staging lung cancerLung Cancer, 2004
- Lymph Node Staging in Lung Cancer Using [18F]FDG-PETThe Thoracic and Cardiovascular Surgeon, 2004
- Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed TomographyNew England Journal of Medicine, 2003
- Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative reviewThe Lancet Oncology, 2001
- PET in oncology: Will it replace the other modalities?Seminars in Nuclear Medicine, 1997
- Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996